Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Columbia University
Abramson Cancer Center at Penn Medicine
Peking University First Hospital
St. Jude Children's Research Hospital
Laikο General Hospital, Athens
Weill Medical College of Cornell University
The University of Texas Health Science Center at San Antonio
Nanjing First Hospital, Nanjing Medical University
Peking University First Hospital
AC Camargo Cancer Center
Fudan University
University of Pennsylvania
Hospices Civils de Lyon
Grupo Espanol de Tumores Neuroendocrinos
British Columbia Cancer Agency
Seoul National University Hospital
Society for Endocrinology
Radboud University Medical Center
Peking Union Medical College Hospital
Fundación de investigación HM
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Universidad Nacional Autonoma de Mexico
King's College Hospital NHS Trust
University of Avignon
Peking Union Medical College Hospital
Radboud University Medical Center
Leiden University Medical Center
University of California, Los Angeles
Children's Hospital Medical Center, Cincinnati
Asan Medical Center
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Rigshospitalet, Denmark
Assistance Publique Hopitaux De Marseille
Radio Isotope Therapy of America
Excel Diagnostics and Nuclear Oncology Center
Peking Union Medical College Hospital
Gustave Roussy, Cancer Campus, Grand Paris
Assistance Publique - Hôpitaux de Paris
Nanjing First Hospital, Nanjing Medical University
University of Iowa
University Medical Centre Ljubljana
British Columbia Cancer Agency
M.D. Anderson Cancer Center
Mercy Research
University of California, San Francisco
University of Warmia and Mazury
University of California, San Francisco
Assistance Publique - Hôpitaux de Paris